These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2437283)

  • 21. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Coker LD; Turnbull TA; Morita ET
    J Clin Invest; 1989 Oct; 84(4):1220-5. PubMed ID: 2794058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cholecystokinin in the inhibition of gastric acid secretion in dogs.
    Konturek SJ; Bilski J; Tasler J; Cieszkowski M
    J Physiol; 1992; 451():477-89. PubMed ID: 1403819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of CCK antagonist L 364718 on meal-induced pancreatic secretion in rats.
    O'Rourke MF; Reidelberger RD; Solomon TE
    Am J Physiol; 1990 Feb; 258(2 Pt 1):G179-84. PubMed ID: 1689547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
    Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H
    Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of cholecystokinin in the intestinal fat- and acid-induced inhibition of gastric secretion.
    Konturek SJ; Bilski J; Cieszkowski M
    Regul Pept; 1992 Nov; 42(1-2):97-109. PubMed ID: 1475410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of cholecystokinin, gastrin and gastrin-releasing peptide in the regulation of pancreatic secretion in cats.
    Konturek SJ; Bilski J; Hladij M; Krzyzek E; Cai RZ; Schally AV
    Digestion; 1991; 49(2):97-105. PubMed ID: 1724767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of L364718 on interdigestive pancreatic exocrine secretion and gastroduodenal motility in conscious sheep.
    Onaga T; Mineo H; Kato S
    Regul Pept; 1997 Jan; 68(2):139-46. PubMed ID: 9110386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors.
    Gully D; Fréhel D; Marcy C; Spinazzé A; Lespy L; Neliat G; Maffrand JP; Le Fur G
    Eur J Pharmacol; 1993 Feb; 232(1):13-9. PubMed ID: 7681406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrin-releasing peptide and cholecystokinin in the regulation of exocrine pancreatic secretion in dogs.
    Nustede R; Schmidt WE; Lohmann C; Köhler H; Schlemminger R; Schafmayer A
    Digestion; 1993; 54(2):79-83. PubMed ID: 8319843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of metoclopramide, bethanechol and the cholecystokinin receptor antagonist, L-364,718, on gastric emptying in the rat.
    Decktor DL; Pendleton RG; Elnitsky AT; Jenkins AM; McDowell AP
    Eur J Pharmacol; 1988 Mar; 147(2):313-6. PubMed ID: 3366182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of postprandial function in the proximal gastrointestinal tract. Role of CCK and sensory pathways.
    Raybould HE; Lloyd KC
    Ann N Y Acad Sci; 1994 Mar; 713():143-56. PubMed ID: 8185155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.
    Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I
    Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of cholecystokinin on gastric motility in humans.
    Beglinger C
    Ann N Y Acad Sci; 1994 Mar; 713():219-25. PubMed ID: 8185162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous cholecystokinin release responsible for pancreatic growth observed after pancreatic juice diversion.
    Rivard N; Guan D; Maouyo D; Grondin G; Bérubé FL; Morisset J
    Endocrinology; 1991 Dec; 129(6):2867-74. PubMed ID: 1954873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous cholecystokinin in the control of gastric emptying of liquid nutrient loads in rhesus monkeys.
    Moran TH; Ameglio PJ; Schwartz GJ; Peyton HJ; McHugh PR
    Am J Physiol; 1993 Aug; 265(2 Pt 2):R371-5. PubMed ID: 8368391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats. Studies with L 364718, a specific inhibitor of CCK-receptor binding.
    Rossetti L; Shulman GI; Zawalich WS
    Diabetes; 1987 Oct; 36(10):1212-5. PubMed ID: 3308589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat.
    Green T; Dimaline R; Peikin S; Dockray GJ
    Am J Physiol; 1988 Nov; 255(5 Pt 1):G685-9. PubMed ID: 3056036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs.
    Konturek SJ; Tasler J; Konturek JW; Cieszkowski M; Szewczyk K; Hładij M; Anderson PS
    Gut; 1989 Jan; 30(1):110-7. PubMed ID: 2920915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous assessment of gastric emptying and secretion in rats by a novel computed tomography-based method.
    Jordi J; Verrey F; Lutz TA
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G173-82. PubMed ID: 24264048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of L-364,718 (CCK receptor antagonist) on exocrine pancreatic secretion of hydrocortisone-treated rats.
    De Dios I; Manso MA
    Pancreas; 1994 Mar; 9(2):212-8. PubMed ID: 7514791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.